Nanotechnology is a branch of engineering that deals with the design and manufacture of very small things. It is a rapidly growing field, with many applications in healthcare. Nanomedicine is one such application, which uses nanotechnology to develop new drugs and treatments for diseases. Nano medical devices are another application, which use nanotechnology to create new devices for diagnosis and treatment of diseases. The global nanotechnology for healthcare market was valued at USD 3.2 billion in 2017 and is expected to reach USD 7.8 billion by 2030, growing at a CAGR of 12% from 2018-2030.
Nanotechnology is a branch of engineering that deals with the design and manufacture of extremely small electronic devices, materials, and systems. The healthcare industry has been one of the most active in adopting nanotechnology.
- Rising incidence of cancer and other life threatening diseases - Increasing prevalence of antibiotic resistant bacteria - Advances in nanomedicine research.
Industry Growth Insights published a new data on “Nanotechnology for Healthcare Market”. The research report is titled “Nanotechnology for Healthcare Market research by Types (Nanomedicine, Nano Medical Devices, Nano Diagnosis, Other, Nanotechnology for Healthcar), By Applications (Anticancer, CNS Product, Anti-infective, Other), By Players/Companies Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International, Nanotechnology for Healthcar”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nanotechnology for Healthcare Market Research Report
By Type
Nanomedicine, Nano Medical Devices, Nano Diagnosis, Other, Nanotechnology for Healthcar
By Application
Anticancer, CNS Product, Anti-infective, Other
By Companies
Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International, Nanotechnology for Healthcar
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Nanotechnology for Healthcare Market Report Segments:
The global Nanotechnology for Healthcare market is segmented on the basis of:
Types
Nanomedicine, Nano Medical Devices, Nano Diagnosis, Other, Nanotechnology for Healthcar
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anticancer, CNS Product, Anti-infective, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amgen
- Teva Pharmaceuticals
- Abbott
- UCB
- Roche
- Celgene
- Sanofi
- Merck & Co
- Biogen
- Stryker
- Gilead Sciences
- Pfizer
- 3M Company
- Johnson & Johnson
- Smith & Nephew
- Leadiant Biosciences
- Kyowa Hakko Kirin
- Shire
- Ipsen
- Endo International
- Nanotechnology for Healthcar
Highlights of The Nanotechnology for Healthcare Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nanomedicine
- Nano Medical Devices
- Nano Diagnosis
- Other
- Nanotechnology for Healthcar
- By Application:
- Anticancer
- CNS Product
- Anti-infective
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nanotechnology for Healthcare Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nanotechnology is a field of engineering and science that deals with the manipulation of matter on an atomic or molecular scale. Nanotechnology has the potential to revolutionize healthcare by allowing doctors to diagnose and treat diseases more accurately, quickly, and inexpensively. For example, nanotech could be used to create tiny sensors that can detect cancer cells in blood samples or tumors in tissue samples. These sensors would then allow doctors to monitor patients more closely for signs of disease progression or relapse.
Some of the major players in the nanotechnology for healthcare market are Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International, Nanotechnology for Healthcar.
The nanotechnology for healthcare market is expected to register a CAGR of 12%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nanotechnology for Healthcare Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nanotechnology for Healthcare Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nanotechnology for Healthcare Market - Supply Chain
4.5. Global Nanotechnology for Healthcare Market Forecast
4.5.1. Nanotechnology for Healthcare Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nanotechnology for Healthcare Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nanotechnology for Healthcare Market Absolute $ Opportunity
5. Global Nanotechnology for Healthcare Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nanotechnology for Healthcare Market Size and Volume Forecast by Type
5.3.1. Nanomedicine
5.3.2. Nano Medical Devices
5.3.3. Nano Diagnosis
5.3.4. Other
5.3.5. Nanotechnology for Healthcar
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nanotechnology for Healthcare Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nanotechnology for Healthcare Market Size and Volume Forecast by Application
6.3.1. Anticancer
6.3.2. CNS Product
6.3.3. Anti-infective
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nanotechnology for Healthcare Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nanotechnology for Healthcare Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nanotechnology for Healthcare Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nanotechnology for Healthcare Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nanotechnology for Healthcare Demand Share Forecast, 2019-2026
9. North America Nanotechnology for Healthcare Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nanotechnology for Healthcare Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nanotechnology for Healthcare Market Size and Volume Forecast by Application
9.4.1. Anticancer
9.4.2. CNS Product
9.4.3. Anti-infective
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nanotechnology for Healthcare Market Size and Volume Forecast by Type
9.7.1. Nanomedicine
9.7.2. Nano Medical Devices
9.7.3. Nano Diagnosis
9.7.4. Other
9.7.5. Nanotechnology for Healthcar
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nanotechnology for Healthcare Demand Share Forecast, 2019-2026
10. Latin America Nanotechnology for Healthcare Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nanotechnology for Healthcare Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nanotechnology for Healthcare Market Size and Volume Forecast by Application
10.4.1. Anticancer
10.4.2. CNS Product
10.4.3. Anti-infective
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nanotechnology for Healthcare Market Size and Volume Forecast by Type
10.7.1. Nanomedicine
10.7.2. Nano Medical Devices
10.7.3. Nano Diagnosis
10.7.4. Other
10.7.5. Nanotechnology for Healthcar
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nanotechnology for Healthcare Demand Share Forecast, 2019-2026
11. Europe Nanotechnology for Healthcare Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nanotechnology for Healthcare Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nanotechnology for Healthcare Market Size and Volume Forecast by Application
11.4.1. Anticancer
11.4.2. CNS Product
11.4.3. Anti-infective
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nanotechnology for Healthcare Market Size and Volume Forecast by Type
11.7.1. Nanomedicine
11.7.2. Nano Medical Devices
11.7.3. Nano Diagnosis
11.7.4. Other
11.7.5. Nanotechnology for Healthcar
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nanotechnology for Healthcare Demand Share, 2019-2026
12. Asia Pacific Nanotechnology for Healthcare Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nanotechnology for Healthcare Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nanotechnology for Healthcare Market Size and Volume Forecast by Application
12.4.1. Anticancer
12.4.2. CNS Product
12.4.3. Anti-infective
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nanotechnology for Healthcare Market Size and Volume Forecast by Type
12.7.1. Nanomedicine
12.7.2. Nano Medical Devices
12.7.3. Nano Diagnosis
12.7.4. Other
12.7.5. Nanotechnology for Healthcar
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nanotechnology for Healthcare Demand Share, 2019-2026
13. Middle East & Africa Nanotechnology for Healthcare Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nanotechnology for Healthcare Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nanotechnology for Healthcare Market Size and Volume Forecast by Application
13.4.1. Anticancer
13.4.2. CNS Product
13.4.3. Anti-infective
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nanotechnology for Healthcare Market Size and Volume Forecast by Type
13.7.1. Nanomedicine
13.7.2. Nano Medical Devices
13.7.3. Nano Diagnosis
13.7.4. Other
13.7.5. Nanotechnology for Healthcar
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nanotechnology for Healthcare Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Nanotechnology for Healthcare Market: Market Share Analysis
14.2. Nanotechnology for Healthcare Distributors and Customers
14.3. Nanotechnology for Healthcare Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Amgen
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Teva Pharmaceuticals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. UCB
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Roche
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Celgene
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sanofi
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Merck & Co
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biogen
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Stryker
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Gilead Sciences
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Pfizer
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. 3M Company
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Johnson & Johnson
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Smith & Nephew
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Leadiant Biosciences
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Kyowa Hakko Kirin
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Shire
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Ipsen
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Endo International
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
